Piramal Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

252.20

-9.40 (-3.59%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

252.20

-9.40 (-3.59%)
16:02 Dec 20

Quality

80/100
High Financial Strength

Valuation

22/100
Expensive Valuation

Technical

63/100
Technically Moderately Bullish

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	6314.9	6559.1	7081.55	8171.16	8703.82
Operating Expenses +	4886.94	5609.44	6453.31	6974.9	7359.42
Raw Material	2111.85	2396.03	2634.66	3152.6	3447.86
Increase Decrease in Cost	-52.74	55.21	68.64	-198.6	-287.48
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	1467.74	1588.83	1896.35	2029.5	2157.15
Miscellaneous Expenses	2463.35	3227.51	3758.06	4342.94	2041.89
Operating Profit	1427.96	949.66	628.24	1196.26	1344.4
Other Income	164.11	275.8	225.11	175.39	168.54
Depreciation	545.04	586.18	676.69	740.57	759.22
Interest	163.45	198.25	344.18	448.49	434.7
Profit before tax and exceptio..	883.58	441.03	-167.52	182.59	319.02
Exceptional Items	18.23	-15.08	-6.96	-62.79	-62.79
PBT	901.81	425.95	-174.48	119.8	381.81
Provision for Taxation	114.02	109.02	66.31	161.47	276.55
Net Profit	787.79	316.93	-240.79	-41.67	-20.32
NET Profit after MI	835.03	375.96	-186.46	17.82	45.33
EPS	18.56	3.19	-1.57	0.14	0.35
Operating Profit Margin (%)	22.61	14.48	8.87	14.64	15.45
Net Profit Margin (%)	13.22	5.73	-2.63	0.22	0.52

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	35.00	35.00	35.00	35.00	35.00
FII	31.70	31.40	30.60	32.50	32.40
MF	11.20	10.10	9.00	6.30	3.80
Public	19.10	20.20	21.90	22.40	24.20
Others	0.40	0.40	0.40	0.40	0.40
Others	2.60	2.90	3.10	3.40	4.20